---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-042922"
form_type: "8-K"
ticker: "LUCD"
cik: "0001799011"
company_name: "Lucid Diagnostics Inc."
filed_at: "2023-11-28T23:59:59+00:00"
generated_at: "2026-06-07T21:06:38.536310+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Lucid Diagnostics transfers Nasdaq listing to Capital Market after Global Market non-compliance

## Summary
- Received Nasdaq approval on Nov 27, 2023 to transfer common stock listing from Global Market to Capital Market.
- Transfer effective Nov 29, 2023; trading symbol LUCD unchanged.
- Company was not in compliance with Equity standard for continued listing on Nasdaq Global Market.
- Company meets continued listing standards for Nasdaq Capital Market, resolving the deficiency.

## SEC filing metadata
- accession: 0001493152-23-042922
- form_type: 8-K
- ticker: LUCD
- cik: 0001799011
- company_name: Lucid Diagnostics Inc.
- filed_at: 2023-11-28T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799011/000149315223042922/0001493152-23-042922-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799011/000149315223042922/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-042922
- JSON: https://secwatch.observer/filing/0001493152-23-042922.json
- Plain text: https://secwatch.observer/filing/0001493152-23-042922.txt

## Key facts
- Listing & Compliance Notices
  Lucid Diagnostics Inc. received a nasdaq deficiency notice notice regarding market value.
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: market value
  source text: received a notice from the Nasdaq Listing Qualifications Department stating that the Company was no longer in compliance with the Equity standard for continued listing on the Nasdaq Global Market (and that the Company did not meet the alternative standards for Market Value or Total Assets/Total Revenue). Upon the transfer of the listing of the Company’s common stock to the Nasdaq Capital Market, this deficiency will be resolved because the Company presently meets the continued listing standards for the Nasdaq Capital Market.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799011/000149315223042922/0001493152-23-042922-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.